PHARMAX HOLDING LIMITED
Get an alert when PHARMAX HOLDING LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£10M
+3.4% vs 2023
Employees
0
Average over period
Profit before tax
£440K
-8.9% vs 2023
Net assets
2-year trend · vs Unclassified median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £1,483 | £0 | |
| Profit before tax | £483,321 | £440,326 | |
| Net profit | £369,904 | £329,874 | |
| Cash | — | — | |
| Total assets less current liabilities | — | — | |
| Net assets | £9,793,180 | £10,123,054 | |
| Equity | £9,793,180 | £10,123,054 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 25.83x | 22.81x | |
| Interest cover | — | 0.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Affirmed
“The company has adequate financial resources and as a result the director believes that the company is well placed to manage its business risks successfully. The director having assessed the responses of the company's ultimate parent company, AbbVie Inc., to his enquiries has no reason to believe that a material uncertainty exists which may cast significant doubt about the ability of the company to continue as a going concern, or its ability to continue as part of the UK operations. Thus he is adopting, and will continue to adopt, the going concern basis of accounting in preparing the annual financial statements.”
Group structure
- PHARMAX HOLDING LIMITED · parent
- Allergan Sales LLC 100%
Significant events
- “Pillar Two legislation was enacted in 2023 in the United Kingdom and came into effect as of 1 January 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUDSON, Nicholas Iain, Mr. | Director | 2016-10-03 | Nov 1975 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HART, Richard William | Secretary | 1988-01-06 | 1997-11-30 |
| LIVINGSTONE, Andrew John Robertson | Secretary | 1998-04-01 | 2015-11-19 |
| MORE, William Jamieson | Secretary | 1988-09-23 | 1998-03-31 |
| NELLIGAN, Tom | Secretary | 2015-11-19 | 2017-10-13 |
| BURROWS, Robin John | Director | 1984-09-21 | 1986-09-29 |
| JAKES, Nadine | Director | 2015-03-30 | 2016-08-02 |
| MCDONALD, Michael | Director | 2014-04-02 | 2015-03-30 |
| REAVES, Duncan James | Director | 2016-08-02 | 2016-10-03 |
| SOLOMAN, Howard | Director | 1984-09-21 | 2014-03-31 |
| STAFFORD, Raymond Thomas | Director | 1997-11-26 | 2014-04-02 |
| VINCENT, Sara Jayne | Director | 2015-03-30 | 2016-08-02 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 86 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-21 | AA | accounts | Accounts with accounts type full | |
| 2024-10-04 | AA | accounts | Accounts with accounts type full | |
| 2023-10-31 | AA | accounts | Accounts with accounts type full | |
| 2022-07-12 | AA | accounts | Accounts with accounts type full | |
| 2021-05-21 | AA | accounts | Accounts with accounts type full | |
| 2020-11-19 | AA | accounts | Accounts with accounts type full | |
| 2020-09-08 | OSCH01 | other | Change company details by uk establishment overseas company with change details | |
| 2019-11-27 | AA | accounts | Accounts with accounts type full | |
| 2018-09-04 | AA | accounts | Accounts with accounts type full | |
| 2018-05-25 | AA | accounts | Accounts with accounts type full | |
| 2017-11-22 | OSTM02 | officers | Termination person secretary overseas company with name termination date | |
| 2017-09-13 | AA | accounts | Accounts with accounts type full | |
| 2017-08-15 | AA01 | accounts | Change account reference date company previous shortened | |
| 2017-02-16 | OSCH02 | other | Change company details overseas company with change details | |
| 2017-02-16 | OSCH02 | other | Change company details overseas company | |
| 2016-11-21 | OSTM02 | officers | Termination person secretary overseas company with name termination date | |
| 2016-11-21 | OSAP03 | officers | Appoint person secretary overseas company with appointment date | |
| 2016-11-21 | OSTM01 | officers | Termination person director overseas company with name termination date | |
| 2016-11-21 | OSAP01 | officers | Appoint person director overseas company with name appointment date | |
| 2016-10-04 | OSCH01 | other | Change company details by uk establishment overseas company with change details |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
+3.4%
£9,793,180 £10,123,054
-
Employees
—
Not reported
-
Operating profit
-100%
£1,483 £0
-
Profit before tax
-8.9%
£483,321 £440,326
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers